Search

Hydrogels are widely used for therapeutic delivery applications due to their biocompatibility, biodegradability, and ability to control release kinetics by tuning swelling and mechanical properties. However, their clinical utility is hampered by unfavorable pharmacokinetic properties, including high initial burst release and difficulty in achieving prolonged release, especially for small molecules (<500 Da). The incorporation of nanomaterials within hydrogels has emerged as viable option as a method to trap therapeutics within the hydrogel and sustain release kinetics. Specifically, two-dimensional nanosilicate particles offer a plethora of beneficial characteristics, including dually charged surfaces, degradability, and enhanced mechanical properties within hydrogels. The nanosilicate–hydrogel composite system offers benefits not obtainable by just one component, highlighting the need for detail characterization of these nanocomposite hydrogels. This review focuses on Laponite, a disc-shaped nanosilicate with diameter of 30 nm and thickness of 1 nm. The benefits of using Laponite within hydrogels are explored, as well as examples of Laponite–hydrogel composites currently being investigated for their ability to prolong the release of small molecules and macromolecules such as proteins. Future work will further characterize the interplay between nanosilicates, hydrogel polymer, and encapsulated therapeutics, and how each of these components affect release kinetics and mechanical properties. [ABSTRACT FROM AUTHOR]

Herein, a method that uses direct‐ink‐write printing to fabricate engineering living materials (ELMs) that respond by undergoing a programmed shape change in response to specific molecules is reported. Stimuli‐responsiveness is imparted to ELMs by integrating genetically engineered yeast that only proliferate in the presence of specific biomolecules. This proliferation, in turn, leads to a shape change in the ELM in response to that biomolecule. These ELMs are fabricated by coprinting bioinks that contain multiple yeast strains. Locally, cellular proliferation leads to controllable shape change of the material resulting in up to a 370% increase in volume. Globally, the printed 3D structures contain regions of material that increase in volume and regions that do not under a given set of conditions, leading to programmable changes in form in response to target amino acids and nucleotides. Finally, this printing method is applied to design a reservoir‐based drug delivery system for the on‐demand delivery of a model drug in response to a specific biomolecule. [ABSTRACT FROM AUTHOR]

Belousov–Zhabotinsky (BZ) reactions have been used to investigate periodic spatial patterns due to the oscillatory nature of the reaction. However, these systems have not been confined, nor controlled, in macro‐scaled architectures, making it hard to translate observations to natural behavior. Here, a poly(electrolyte) complex is designed that can be ionically or covalently reinforced to construct 3D geometries with additive manufacturing techniques. Printed geometries varied in shape, size, and angle to investigate spatiotemporal pattern formation in 3D. Size variations correlated to trends in oscillating pattern frequencies, demonstrating a geometry effect on spatial alterations. Overall, the combination of 3D printing techniques with self‐oscillating chemical reactions allows to model, study, and further understand macro‐scale patterns observed in nature. The proposed approach can be used to design smart structure to replicate biological oscillators such as cardiac arrhythmias, neuron signaling, and camouflage skin patterns. [ABSTRACT FROM AUTHOR]

Engineered biomaterials are materials specifically designed to interact with biological systems for biomedical applications. This paper offers the comprehensive analysis of global clinical trial trends involving such materials. We surveyed 834 studies in the ClinicalTrials.gov database and explored biomaterial types, their initiation points, and durations in clinical trials. Predominantly, synthetic and natural polymers, particularly silicone and collagen, are used. Trials, focusing on ophthalmology, dentistry, and vascular medicine, are primarily conducted in the United States, Canada, and Italy. These trials encompass a broad demographic, and trials enrolled fewer than 100 participants. The study duration varied ranging from 0.5 to 4.5 years. These biomaterials are mainly bioresorbable or bioinert, with the integration of cells in biomaterials remaining an underexplored area. Our findings shed light on current practices and future potentials of engineered biomaterials in clinical research, offering insights for advancing this dynamic field globally. [ABSTRACT FROM AUTHOR]

The article presents an investigation via both experimental and computational methods on the hydrogel microparticle (HMP) dissipation process during printing as a result of external resistance from the printing apparatus and internal physiochemical properties of HMPs. Topics discussed include initiation of HMP flow for three-dimensional (3D) bioprinting, influence of the extent of HMP jamming on printing flow and stability, and fabrication of microfluidic HMPs.